Non Alcoholic Fatty Liver Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GALT | A | Galectin Therapeutics Inc. | -1.43 | |
VKTX | B | Viking Therapeutics, Inc. | 7.91 | |
BLTE | C | Belite Bio, Inc. | 4.61 | |
GYRE | D | Gyre Therapeutics, Inc. | 4.78 | |
ALGS | D | Aligos Therapeutics, Inc. | -4.40 | |
GNFT | F | GENFIT S.A. | 1.16 | |
IVA | F | Inventiva S.A. | 2.85 | |
PLRX | F | Pliant Therapeutics, Inc. | -0.59 | |
ETNB | F | 89bio, Inc. | 0.12 | |
TERN | F | Terns Pharmaceuticals, Inc. | 5.82 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services
Related ETFs - A few ETFs which own one or more of the above listed Non Alcoholic Fatty Liver Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 5.7 | |
ULTY | D | Tidal Trust II YieldMax Ultra Option Income Strategy ETF | 5.68 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 5.51 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 2.12 | |
XBI | D | SPDR S&P Biotech ETF | 1.59 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Health Information Services
- Non Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles